Your browser doesn't support javascript.
loading
Nilotinib 300 mg BID as frontline treatment of CML: prospective analysis of the Xpert BCR-ABL monitor system and significance of 3-month molecular response.
O'Dwyer, Michael E; Swords, Ronan; Nagler, Arnon; McMullin, Mary Frances; le Coutre, Philipp D; Langabeer, Stephen E; Alvarez-Iglesias, Alberto; Fan, Hongxin; Woodman, Richard C; Giles, Francis J; Conneally, Eibhlin.
Afiliación
  • O'Dwyer ME; HRB Clinical Research Facility, National University of Ireland, Galway, Ireland. Electronic address: michael.odwyer@nuigalway.ie.
  • Swords R; Leukemia Program, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA.
  • Nagler A; Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • McMullin MF; Center for Cancer Research and Cell Biology, Queens University, Belfast, Northern Ireland, United Kingdom.
  • le Coutre PD; Division of Oncology and Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Langabeer SE; Department of Hematology, St. James's Hospital, Dublin, Ireland.
  • Alvarez-Iglesias A; HRB Clinical Research Facility, National University of Ireland, Galway, Ireland.
  • Fan H; Molecular Diagnostics Laboratory, University of Texas Health Science Center San Antonio, San Antonio, USA.
  • Woodman RC; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Giles FJ; Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.
  • Conneally E; Department of Hematology, St. James's Hospital, Dublin, Ireland.
Leuk Res ; 38(3): 310-5, 2014 Mar.
Article en En | MEDLINE | ID: mdl-24333114
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Monitoreo de Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirimidinas / Leucemia Mielógena Crónica BCR-ABL Positiva / Proteínas de Fusión bcr-abl / Monitoreo de Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2014 Tipo del documento: Article